Cathie Wood-led Ark Invest on Wednesday snapped up shares in Ginkgo Bioworks Holdings Inc (NYSE: DNA) on the day the synthetic biology company stock was hit hard by
Here is the statement from the company CEO, Jason Kelly
"Our focus at Ginkgo is increasing the scale of our platform so we can deliver more cell programs to customers. We were doing that yesterday, we'reHere is the statement from the company CEO, Jason Kelly